Literature DB >> 24825596

Evaluation of 6- and 12-month supervised exercise training on strength and endurance parameters in patients with peripheral arterial disease.

Magdalena Pilz1, Elisabeth Kandioler-Honetz, Alfa Wenkstetten-Holub, Waltraud Doerrscheidt, Rudolf Mueller, Robert Wolfgang Kurz.   

Abstract

BACKGROUND: The classic symptom of peripheral arterial disease is the intermittent claudication (IC). Generally, endurance training is recommended to improve patients' walking performance. A potential benefit of the combination with strength training and the optimal duration of such an exercise program remain unclear. METHODS AND
RESULTS: We evaluated the effects of a supervised exercise program combining endurance and strength training lasting 6 or 12 months in patients with IC. A total of 94 patients joined this study; 42 completed the 6-month training program (group A), whereas 52 patients completed the 12-month protocol (group B). Both groups exhibited a significant increase in all parameters evaluated, but greater benefit was found in the 12-month training group. The absolute claudication distance increased similarly by 27.5 and 29.5 %, respectively, in both groups (not significant); however, group B exhibited a greater increase in walking speed (12.1 vs. 5.3 %, p < 0.001). All strength parameters increased significantly in both the groups showing an increase for "pushing" by 90.0 % (group A) and 90.2 % (group B), for "pulling" by 64.2 % (group A) and 75.3 % (group B), and for "tiptoe standing" by 70.5 % (group A) and 113.7 % (group B; p < 0.05).
CONCLUSION: The results of this study indicate that a combined exercise program significantly increases walking speed, absolute claudication distance, and muscle strength parameters. A greater benefit seems to result from a 12-month training program.

Entities:  

Mesh:

Year:  2014        PMID: 24825596     DOI: 10.1007/s00508-014-0548-y

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  37 in total

1.  Neuromuscular adaptations during concurrent strength and endurance training versus strength training.

Authors:  K Häkkinen; M Alen; W J Kraemer; E Gorostiaga; M Izquierdo; H Rusko; J Mikkola; A Häkkinen; H Valkeinen; E Kaarakainen; S Romu; V Erola; J Ahtiainen; L Paavolainen
Journal:  Eur J Appl Physiol       Date:  2002-12-14       Impact factor: 3.078

2.  The effect of a 3-month supervised exercise programme on gait parameters of patients with peripheral arterial disease and intermittent claudication.

Authors:  Stephanie King; Natalie Vanicek; Katherine A Mockford; Patrick A Coughlin
Journal:  Clin Biomech (Bristol, Avon)       Date:  2012-06-02       Impact factor: 2.063

3.  Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training--randomized controlled trial.

Authors:  Sandra Spronk; Johanna L Bosch; Pieter T den Hoed; Hermanus F Veen; Peter M T Pattynama; M G Myriam Hunink
Journal:  Radiology       Date:  2009-02       Impact factor: 11.105

4.  ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).

Authors:  Michal Tendera; Victor Aboyans; Marie-Louise Bartelink; Iris Baumgartner; Denis Clément; Jean-Philippe Collet; Alberto Cremonesi; Marco De Carlo; Raimund Erbel; F Gerry R Fowkes; Magda Heras; Serge Kownator; Erich Minar; Jan Ostergren; Don Poldermans; Vincent Riambau; Marco Roffi; Joachim Röther; Horst Sievert; Marc van Sambeek; Thomas Zeller
Journal:  Eur Heart J       Date:  2011-08-26       Impact factor: 29.983

Review 5.  Biomarkers of peripheral arterial disease.

Authors:  John P Cooke; Andrew M Wilson
Journal:  J Am Coll Cardiol       Date:  2010-05-11       Impact factor: 24.094

6.  Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment.

Authors:  M M McDermott; P Greenland; K Liu; J M Guralnik; M H Criqui; N C Dolan; C Chan; L Celic; W H Pearce; J R Schneider; L Sharma; E Clark; D Gibson; G J Martin
Journal:  JAMA       Date:  2001-10-03       Impact factor: 56.272

7.  Supervised exercise therapy for intermittent claudication.

Authors:  B L W Bendermacher; L M Kruidenier; S P A Nicolaï; R J Th J Welten; J A W Teijink
Journal:  Acta Chir Belg       Date:  2007 Nov-Dec       Impact factor: 1.090

8.  Isokinetic strength and endurance in peripheral arterial insufficiency with intermittent claudication.

Authors:  B Gerdle; B Hedberg; K A Angquist; A R Fugl-Meyer
Journal:  Scand J Rehabil Med       Date:  1986

9.  Measurement of walking distance and speed in patients with peripheral arterial disease: a novel method using a global positioning system.

Authors:  Alexis Le Faucheur; Pierre Abraham; Vincent Jaquinandi; Philippe Bouyé; Jean Louis Saumet; Bénédicte Noury-Desvaux
Journal:  Circulation       Date:  2008-02-04       Impact factor: 29.690

10.  Lower extremity ischemia, calf skeletal muscle characteristics, and functional impairment in peripheral arterial disease.

Authors:  Mary M McDermott; Frederick Hoff; Luigi Ferrucci; William H Pearce; Jack M Guralnik; Lu Tian; Kiang Liu; Joseph R Schneider; Leena Sharma; Jin Tan; Michael H Criqui
Journal:  J Am Geriatr Soc       Date:  2007-03       Impact factor: 5.562

View more
  6 in total

Review 1.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

Review 2.  Supervised exercise therapy versus home-based exercise therapy versus walking advice for intermittent claudication.

Authors:  David Hageman; Hugo Jp Fokkenrood; Lindy Nm Gommans; Marijn Ml van den Houten; Joep Aw Teijink
Journal:  Cochrane Database Syst Rev       Date:  2018-04-06

3.  The Impact of Walking Exercises and Resistance Training upon the Walking Distance in Patients with Chronic Lower Limb Ischaemia.

Authors:  Maria Szymczak; Grzegorz Oszkinis; Marian Majchrzycki
Journal:  Biomed Res Int       Date:  2016-10-19       Impact factor: 3.411

Review 4.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

Review 5.  Sarcopenia and peripheral arterial disease: a systematic review.

Authors:  Mégane Pizzimenti; Alain Meyer; Anne-Laure Charles; Margherita Giannini; Nabil Chakfé; Anne Lejay; Bernard Geny
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-07-10       Impact factor: 12.910

6.  Influence of the Physical Training on Muscle Function and Walking Distance in Symptomatic Peripheral Arterial Disease in Elderly.

Authors:  Katarzyna Kropielnicka; Wioletta Dziubek; Katarzyna Bulińska; Małgorzata Stefańska; Joanna Wojcieszczyk-Latos; Ryszard Jasiński; Urszula Pilch; Grażyna Dąbrowska; Katarzyna Skórkowska-Telichowska; Dariusz Kałka; Agnieszka Janus; Katarzyna Zywar; Rafał Paszkowski; Anna Rachwalik; Marek Woźniewski; Andrzej Szuba
Journal:  Biomed Res Int       Date:  2018-09-23       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.